BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2609738)

  • 1. [Intra-arterial infusion therapy of progressive diabetic foot gangrene with prostaglandin E1 amd cefotaxime].
    Krawzak HW; Jäkel F; Strosche H; Buchholz J
    Vasa; 1989; 18(4):312-5. PubMed ID: 2609738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current surgery/drug combination treatment of diabetic gangrene of the foot.
    Lange E
    Infection; 1991; 19 Suppl 6():S351-4. PubMed ID: 1791082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intra-arterial infusion treatment of mixed infection gangrene with cefotaxime sodium].
    Müller-Bühl U; Diehm C
    Med Klin (Munich); 1986 Nov; 81(23):751-2. PubMed ID: 3807823
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M; Iacobitti P; Laurora G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
    Hinderer S; Brachmann R; Nedder KH; Bucher J; Beischer W
    Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of intravenous infusion of prostaglandin E1 on cutaneous microcirculation in black foot disease.
    Kwan CM; Chang WC; Chen JH; Wang MY
    J Formos Med Assoc; 1993 Jul; 92(7):603-8. PubMed ID: 7904494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous intra-arterial perfusion of prostaglandin E1 in inoperable stage-IV arteriopathies].
    Gruss JD; Bartels D; Haidar A; Vargas H; Simmenroth H
    J Mal Vasc; 1983; 8(2):133-7. PubMed ID: 6683740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional intra-arterial thrombolytic treatment of venous gangrene of the foot.
    Loberman Z; Kopelman D; Hashmonai M
    Eur J Surg; 1992 Sep; 158(9):513-4. PubMed ID: 1358224
    [No Abstract]   [Full Text] [Related]  

  • 13. The team approach in salvage of the diabetic foot.
    Jacobs RL; Karmody AM; Wirth C; Vedder D
    Surg Annu; 1977; 9():231-64. PubMed ID: 882894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease.
    Apelqvist J; Castenfors J; Larsson J; Stenström A; Persson G
    Int Angiol; 1990; 9(2):120-4. PubMed ID: 2254674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of moist diabetic gangrene].
    Danil'iants EV; Kadoshchuk IuT
    Khirurgiia (Mosk); 1987 Dec; (12):66-9. PubMed ID: 3448376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cefotaxime treatment of osteomyelitis of the foot in the diabetic].
    Herranz A; Barberán J; Gomis M; Alguacil R; Pastor JM
    An Med Interna; 1991 Jun; 8(6):273-80. PubMed ID: 1888840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of gangrene of the lower limbs in diabetes mellitus].
    Ogonovskiĭ VK; Nevzgoda AA
    Vestn Khir Im I I Grek; 1985 May; 134(5):66-8. PubMed ID: 4035927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malum perforans diabeticorum: treatment with controlled circulatory blockade and regional intravenous administration of antibiotics].
    Acevedo A; Decinti E; Toledo L; Pérez O
    Wien Med Wochenschr; 1993; 143(7-8):195-8. PubMed ID: 8379176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.